Catheter Precision, Inc. current report, 17 December 2021

Vollständiges Dokument

Business Context and Reporting Period

This Form 8-K is a current report filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on December 17, 2021. The registrant is a Delaware corporation headquartered in Carlsbad, California, with common stock trading on the NYSE American under the symbol RMED. The report addresses corporate governance changes effective December 31, 2021.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and board composition changes rather than financial performance.

Material Changes

  • Director Resignation: William R. Enquist, Jr. resigned from the Board of Directors, the Nominating and Corporate Governance Committee, and the Compensation Committee, effective December 31, 2021.
  • Reason for Resignation: The resignation was made to comply with California Corporate Code Section 301.3, which mandates minimum female representation on boards for public companies headquartered in California. The filing explicitly states there was no disagreement between Mr. Enquist and the Company.
  • Committee Reassignments:
    • Compensation Committee: Martin Colombatto (Chair) and Susanne L. Meline.
    • Nominating and Corporate Governance Committee: Joan Stafslien (Chair) and Martin Colombatto (newly appointed).
    • Audit Committee: No changes; remains Richard Mejia, Jr. (Chair) and Joan Stafslien.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk addressed is regulatory compliance with California state law regarding board diversity. All remaining directors on the Audit, Compensation, and Nominating and Corporate Governance Committees are confirmed as independent under NYSE American listing standards.

Key Facts for Investor Verification

  • Verify the updated board composition and committee memberships effective December 31, 2021.
  • Confirm the company's ongoing compliance with California Corporate Code Section 301.3 regarding board diversity.
  • Note that the resignation was voluntary and not due to any disagreement with the company.
  • Check subsequent filings for the appointment of a new director to replace Mr. Enquist, if applicable.